NYSE - Delayed Quote • USD
Nevro Corp. (NVRO)
At close: 4:00 PM EDT
After hours: 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 17 | 17 |
| Avg. Estimate | -1.05 | -0.66 | -2.66 | -2.22 |
| Low Estimate | -1.26 | -0.81 | -3.13 | -2.79 |
| High Estimate | -0.77 | -0.52 | -2.19 | -1.47 |
| Year Ago EPS | -0.98 | -0.69 | -2.56 | -2.66 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 16 | 16 | 18 | 18 |
| Avg. Estimate | 97.89M | 111.24M | 441.04M | 467.93M |
| Low Estimate | 97.18M | 107M | 434.6M | 456.3M |
| High Estimate | 98.46M | 114.44M | 449.65M | 482.67M |
| Year Ago Sales | 95.18M | 108.81M | 425.17M | 441.04M |
| Sales Growth (year/est) | 2.80% | 2.20% | 3.70% | 6.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.04 | -0.69 | -0.77 | -0.49 |
| EPS Actual | -0.98 | -0.69 | -0.65 | -0.25 |
| Difference | 0.06 | 0 | 0.12 | 0.24 |
| Surprise % | 5.80% | 0.00% | 15.60% | 49.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.05 | -0.66 | -2.66 | -2.22 |
| 7 Days Ago | -1.05 | -0.66 | -2.66 | -2.22 |
| 30 Days Ago | -1.05 | -0.65 | -2.66 | -2.25 |
| 60 Days Ago | -1.05 | -0.65 | -2.65 | -2.21 |
| 90 Days Ago | -0.8 | -0.6 | -2.49 | -2.02 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | NVRO | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -7.10% | -- | -- | 6.50% |
| Next Qtr. | 4.30% | -- | -- | 12.00% |
| Current Year | -3.90% | -- | -- | 5.30% |
| Next Year | 16.50% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -318.90% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/15/2024 |
| Maintains | Mizuho: Neutral to Neutral | 4/11/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/8/2024 |
| Maintains | Citigroup: Neutral to Neutral | 4/3/2024 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/22/2024 |
| Maintains | Baird: Neutral to Neutral | 2/22/2024 |
Related Tickers
LUNG Pulmonx Corporation
7.28
-0.27%
SILK Silk Road Medical, Inc
17.80
+0.85%
LIVN LivaNova PLC
55.53
+0.78%
SIBN SI-BONE, Inc.
14.57
+2.10%
SGHT Sight Sciences, Inc.
5.28
+2.72%
PRCT PROCEPT BioRobotics Corporation
51.83
-0.86%
PEN Penumbra, Inc.
204.41
-0.53%
FNA Paragon 28, Inc.
8.80
-1.90%
TMCI Treace Medical Concepts, Inc.
10.40
+0.97%
ITGR Integer Holdings Corporation
109.58
-1.41%